N

Nicholas J. Vogelzang

Comprehensive Cancer Centers of Nevada

ORCID: 0000-0002-7665-6079

Publishes on Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments. 1.1k papers and 69.6k citations.

PubIndex Score98Top 2%How it's scored

1.1kPublications

69.6kTotal Citations

First publication: 1973First senior author: 1982

Prostate Cancer Treatment and Research Renal cell carcinoma treatment Bladder and Urothelial Cancer Treatments Radiopharmaceutical Chemistry and Applications Cancer Immunotherapy and Biomarkers

Top publicationsby citations

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Joaquim Bellmunt, Dean F. Bajorin, Ronald de Wit et al.|New England Journal of Medicine|2017

Cited by 3.4k

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Oliver Sartor, Sten Nilsson et al.|New England Journal of Medicine|2013

Cited by 3.3k

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, Paolo Paoletti, James J. Rusthoven et al.|Journal of Clinical Oncology|2003

Cited by 3.1k

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Robert S. DiPaola, Yu‐Hui Chen et al.|New England Journal of Medicine|2015

Cited by 2.8k

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

H. Barton Grossman, E. David Crawford, Ronald B. Natale et al.|New England Journal of Medicine|2003

Cited by 2.6k